Health Conditions

Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial  

This randomized, double blind, placebo-controlled clinical study investigated the effectiveness of Bacopa monniera supplementation on memory performance in healthy older adults. Participants were randomized to receive a placebo or Bacopa, 300 mg per day for 12 weeks and assessed for neuropsychologic and subjective memory assessment at baseline and after 12 weeks of supplementation. Audioverbal and …

Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial   Read More »

An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children  

The aim of this open label clinical study was to investigate the effectiveness of a standardized extract of Bacopa monnieri in improving the severity of ADHD symptoms. Children aged 6-12 years old, with an age of onset prior to 7 years of age were recruited for the study and received 225 mg bacopa extract daily …

An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children   Read More »

Does Branched-Chain Amino Acids (BCAAs) Supplementation Attenuate Muscle Damage Markers and Soreness after Resistance Exercise in Trained Males? A Meta-Analysis of Randomized Controlled Trials    

This meta-analysis published in 2021 relating to the effect of BCAAs supplementation on plasma muscle damage markers and soreness after resistance exercise in only trained males. Nine studies met the inclusion criteria with a total of 278  participants ranging from 21.5 to 24.7 years old. Study length ranged from 1-28 days and supplementation schedules included …

Does Branched-Chain Amino Acids (BCAAs) Supplementation Attenuate Muscle Damage Markers and Soreness after Resistance Exercise in Trained Males? A Meta-Analysis of Randomized Controlled Trials     Read More »

Benfotiamine and cognitive decline in Alzheimer’s disease: Results of a randomized placebo-controlled phase II clinical trial 

This double-blind early phase II randomized placebo-controlled trial published in 2020, was conducted of benfotiamine with the objective of collecting preliminary data on feasibility, safety and efficacy in mild cognitive impairments, mild dementia experienced by Alzheimer’s patients (amyloid positive). Results suggest that benfotiamine offers a low cost, high safety intervention that can improve outcomes for …

Benfotiamine and cognitive decline in Alzheimer’s disease: Results of a randomized placebo-controlled phase II clinical trial  Read More »

Benfotiamine in the treatment of diabetic polyneuropathy – A three-week randomized, controlled pilot study (BEDIP study) 

Published in 2008 this six-week, double blind, placebo-controlled, phase-III-study recruited 165 patients with symmetrical, distal diabetic polyneuropathy. Authors found a dose dependent improvement in the neuropathic symptom scores with the benfotiamine treatment group.     References: Stracke, H., Gaus, W., Achenbach, U., Federlin, K., & Bretzel, R. G. (2008). Benfotiamine in diabetic polyneuropathy (BENDIP): results of a …

Benfotiamine in the treatment of diabetic polyneuropathy – A three-week randomized, controlled pilot study (BEDIP study)  Read More »

Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes 

This human clinical pilot study from 2008 set the basis of future research in whether benfotiamine in combination with α-lipoic acid would normalize markers of reactive oxygen species-induced pathways of complications in humans. Authors found the intervention with oral benfotiamine plus α-lipoic acid normalises several complications-causing pathways in patients with type 1 diabetes.  References: Du, …

Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes  Read More »

Review on pharmacognostic, phytochemical and pharmacological characteristics of medicinal plants which can be used to design a novel ayurvedic formulation to treat hypertension in multidimensional approaches 

This review from 2023 evaluates extraction methods of the active phytoconstituents and pharmacognostic, physiochemical, phytochemical and quantitative analysis parameters, and the different pharmacological modes of action for ayurvedic plants traditionally used for the management of blood pressure. Concluding that Boerhavia diffusa consists of active ingredients: Liriodendron & Syringaresinol mono β-D-Glucosidase which can exhibit Ca2+ channel …

Review on pharmacognostic, phytochemical and pharmacological characteristics of medicinal plants which can be used to design a novel ayurvedic formulation to treat hypertension in multidimensional approaches  Read More »

Pivotal role of boron supplementation on bone health: A narrative review 

This review from 2020 included 11 eligible studies evaluating the effectiveness of boron supplementation (alone or with other micronutrients) on growth and maintenance of bone in humans through control of calcium, vitamin D and sex steroid hormone metabolism. Authors concluded supplementation of 3 mg / day is considered useful to support bone health (in order to …

Pivotal role of boron supplementation on bone health: A narrative review  Read More »

Scroll to Top
×
Why Choose to Sbscribe and Save?
  • Automatically re-order your favorite products on your schedule.
  • Easily change the products or shipping date for your upcoming Scheduled Orders.
  • If you decide a subscription is not for you, it can be cancelled after 3 renewals.